SEMA3A and glioblastoma: Notably, several studies have indicated that endogenous Sema3A can mediate autocrine signaling in GBM PDCs promoting (rather than inhibiting) cell motility; in fact, in both PDCs and immortalized U87MG cells, Sema3A neutralization with different anti-Sema3A antibodies significantly reduced cell migration [28].